Georges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, Edwin Lin, Nicolas Sayegh, Micah Ostrowski, Varun Nandakumar, Chadi Hage Chehade, Richard Ji, Ethan Murdock, Patrick Campbell, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal. "Treatment patterns and outcomes with second line (2L) therapies in patients (pts) with advanced urothelial carcinoma (aUC) previously treated with first line (1L) enfortumab vedotin (EV) with pembrolizumab (pembro).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.676